Publication | Closed Access

Modification of batroxobin with activated polyethylene glycol: Reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs

MedicineImmunoengineeringImmunologyTherapeutic EfficacyDefibrinogenation ActivityAnti-batroxobin AntibodyImmunochemistryAntibody EngineeringAntibody ScreeningPharmacologyActivated Polyethylene Glycol